Noom and Wegovy: Program Model, Semaglutide Sourcing, Cost

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This is a PlexusDx Education Hub article, covering GLP-1 medications, the telehealth programs that dispense them, and the genetic groundwork behind any weight-management decision. Browse all Peptides & GLP-1 education

The following is an independent editorial review. PlexusDx maintains no commercial ties to Noom or its parent company, and no affiliate arrangements or compensation are part of this piece.

People pairing Noom with Wegovy in a search are usually asking how a subscription app handles a branded semaglutide product. Below, we outline Noom's model, how a Wegovy-style prescription is routed and filled, the branded-versus-compounded distinction, what sets the monthly cost, and the pathway genetics that stay invisible to a telehealth intake. Balanced framing, accurate as of April 2026, not a recommendation to buy.

Wegovy and how a Noom prescription reaches the pharmacy

Wegovy is a branded semaglutide product for weight management. Noom (Noom, Inc.) works as an app-based subscription with a medication add-on, so a request in this category typically involves a virtual clinical evaluation, a prescription sent to a retail pharmacy for an FDA-approved brand product like Wegovy or to a 503A compounding pharmacy for compounded semaglutide, and follow-up over time. Noom posts its current structure and pricing on its official website.

Branded Wegovy set against compounded semaglutide

The same active molecule can reach a patient two ways. Branded Wegovy is dispensed through retail channels as an FDA-approved product, while compounded semaglutide is prepared by a 503A pharmacy against a valid prescription under a separate regulatory pathway. Which route a program relies on affects sourcing, oversight and the amount paid. It is worth confirming, before enrolling, whether a given telehealth service is pointing you toward the brand or a compounded formulation.

The steps between intake and a filled semaglutide prescription

A semaglutide request generally advances through a predictable set of stages: the patient completes an intake documenting weight, medical history and current medications; a licensed clinician reviews it and issues a prescription only if eligibility criteria are met; the order is directed to a retail or compounding pharmacy; and virtual follow-up supports dose titration and management of side effects. Programs vary in whether a physician, nurse practitioner or physician assistant handles the review and in how the subscription is packaged.

What shapes the monthly spend on a semaglutide plan

Noom's pricing is published on its own site and moves over time. The monthly figure for a semaglutide plan reflects the specific product, the subscription tier, and whether the pharmacy supplies a branded item like Wegovy or a compounded alternative. Within the telehealth GLP-1 market as of April 2026, totals generally fall somewhere between roughly $200 and $700+, with substantial spread. Because these numbers change often, verify the current cost on the brand's own site before making a commitment.

STEP: the trial evidence behind semaglutide

The pharmacology underneath any legitimate semaglutide program is the compound class itself — GLP-1 receptor agonists including semaglutide, liraglutide and dulaglutide, alongside the GIP/GLP-1 dual agonist tirzepatide. Semaglutide's weight-management evidence comes chiefly from the STEP program, published in The New England Journal of Medicine in 2021. For context, tirzepatide's data come from SURMOUNT (NEJM 2022) and SURMOUNT-OSA (NEJM 2024). Study populations and endpoints differ across these trials, and results vary from person to person.

The genetics a semaglutide program leaves unread

A prescription does not capture the genetic architecture a GLP-1 compound acts within. FTO, the fat-mass and obesity-associated gene, works alongside GLP1R, the receptor gene these medications target, MC4R, a melanocortin receptor at the center of satiety and energy balance, and TCF7L2, a transcription factor linked to glucose regulation and GLP-1 secretion. These pathway-level variants do not predict how semaglutide will perform for a given person, but they describe the terrain a clinician prescribes into — something no intake form records.

Through its Weight Management Protocols, PlexusDx offers semaglutide and tirzepatide as Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral. What differs is the starting point: ahead of any protocol, the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights — FTO, MC4R and TCF7L2 among them — so your baseline appetite and energy-balance biology can shape an informed discussion with your provider. Test before you invest.

Not affiliated: PlexusDx is not affiliated with Noom and holds no commercial relationship with the companies named in this review.

Related reading on PlexusDx: Wegovy Generic, Wegovy Generic Name, Wegovy 24 Mg, Wegovy Cash Price.

Disclaimer: This article is educational. PlexusDx is not affiliated with Noom and has no commercial relationship with the companies reviewed. PlexusDx provides semaglutide and tirzepatide through its own Weight Management Protocols, and this piece compares approaches across the GLP-1 telehealth space. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways — it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Prefer to understand your biology first? Take the Precision Peptide Genetic Test to read your semaglutide pathway, or see the Weight Management Protocols for how PlexusDx combines the compound with genetic context.

Frequently Asked Questions about Noom and Wegovy

Does Noom provide branded Wegovy or compounded semaglutide?

It varies by the program's pharmacy arrangement. A telehealth service may route a prescription to a retail pharmacy for branded Wegovy or to a 503A compounding pharmacy for compounded semaglutide. Because the route affects oversight and price, confirm which one Noom uses on its own website before you enroll.

Is Wegovy the same as Ozempic?

Both contain semaglutide, but they are marketed as separate branded products with different labeled indications and dosing. Wegovy is positioned for weight management. A prescribing clinician selects the appropriate product based on an individual's medical history, goals and eligibility rather than brand name alone.

What does a Wegovy-style plan cost through Noom?

Noom publishes pricing on its site, and it changes over time. Telehealth GLP-1 plans generally range from about $200 to $700+ monthly as of April 2026, depending on the product, subscription tier and dispensing pathway. Verify the current amount directly with the brand before committing to any plan.

Will the genetic test predict how I respond to Wegovy?

No. It does not predict response to Wegovy or any specific medication. The Precision Peptide Genetic Test reads pathway-level variants in FTO, MC4R and TCF7L2 that outline your baseline GLP-1 biology — context that remains useful regardless of which telehealth program issues the prescription.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.